Medicine & Life Sciences
Neoplasms
100%
Poly (ADP-Ribose) Polymerase-1
76%
Drug Repositioning
76%
Tumor Cell Line
70%
Poly(ADP-ribose) Polymerase Inhibitors
62%
Esophageal Neoplasms
60%
Drug Discovery
57%
talazoparib
55%
Therapeutics
54%
DNA Repair-Deficiency Disorders
49%
Tankyrases
47%
Adenocarcinoma
43%
Paintings
42%
tropomyosin kinase
42%
Effector Caspases
41%
Noxae
41%
Homologous Recombination
41%
Genes
41%
Cyclin-Dependent Kinase 5
41%
Synovial Sarcoma
37%
Fanconi Anemia
37%
DNA Repair
36%
Small Interfering RNA
36%
Breast Neoplasms
35%
Apoptosis
35%
Small Molecule Libraries
34%
S Phase
34%
Ionophores
33%
DNA Mismatch Repair
33%
Cytosine
33%
Phosphotransferases
32%
lestaurtinib
31%
In Vitro Techniques
31%
MAP Kinase Signaling System
30%
Pharmaceutical Preparations
30%
Ubiquitin
29%
RNA Interference
29%
Nucleosides
29%
Osteosarcoma
29%
B-Cell Lymphoma
28%
Cell Line
28%
Caspases
28%
Copper
27%
Phosphorylation
27%
PCI 32765
27%
Heterografts
26%
Non-Hodgkin's Lymphoma
26%
Estrogen Receptors
26%
Non-Small Cell Lung Carcinoma
25%
Pharmacology
23%
Chemical Compounds
Lethal
66%
Tankyrase Inhibitor
54%
Drug
47%
Antifibrotic
47%
Small Interfering RNA
38%
Poly(ADPribose)
38%
Ionophore
30%
Molecule
27%
Antimetabolite
20%
Oncogenic
19%
Chemical Library
18%
Inhibition of Growth
18%
Molecular Cluster
18%
Methotrexate
17%
Protein
17%
Co Crystallization
17%
Pipeline
16%
Drug Target
15%
Elesclomol
14%
Application
13%
Antineoplastic Agent
12%
Disorder
11%
Mutation
11%
Disulfiram
10%
Cell Death
7%
Heterogeneity
6%
Ammonium
5%